XNASTLRY
Market cap1.27bUSD
Dec 24, Last price
1.41USD
1D
-1.40%
1Q
-16.07%
IPO
-95.26%
Name
Tilray Inc
Chart & Performance
Profile
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | 2016‑05 | 2015‑05 | |
Income | ||||||||||
Revenues | 788,942 25.80% | 627,124 -0.20% | 628,372 22.47% | |||||||
Cost of revenue | 816,948 | 711,782 | 741,734 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (28,006) | (84,658) | (113,362) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (26,616) | (7,181) | (6,542) | |||||||
Tax Rate | ||||||||||
NOPAT | (1,390) | (77,477) | (106,820) | |||||||
Net income | (244,981) -83.02% | (1,443,000) 232.39% | (434,132) 29.20% | |||||||
Dividends | (7,484,000) | |||||||||
Dividend yield | 346.37% | |||||||||
Proceeds from repurchase of equity | 8,619 | 253,823 | ||||||||
BB yield | -0.64% | -11.75% | ||||||||
Debt | ||||||||||
Debt current | 38,960 | 224,262 | 92,649 | |||||||
Long-term debt | 413,870 | 376,228 | 549,189 | |||||||
Deferred revenue | 113,630 | |||||||||
Other long-term liabilities | 113,720 | 11,104 | 191 | |||||||
Net debt | 184,449 | 139,590 | 210,927 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (30,905) | 7,906 | (177,262) | |||||||
CAPEX | (29,249) | (20,800) | (34,064) | |||||||
Cash from investing activities | 128,349 | (285,111) | (21,533) | |||||||
Cash from financing activities | (75,187) | 70,158 | 128,196 | |||||||
FCF | (290,346) | 276,457 | (194,746) | |||||||
Balance | ||||||||||
Cash | 260,522 | 448,529 | 415,909 | |||||||
Long term investments | 7,859 | 12,371 | 15,002 | |||||||
Excess cash | 228,934 | 429,544 | 399,492 | |||||||
Stockholders' equity | (2,703,632) | (2,447,800) | (941,001) | |||||||
Invested Capital | 6,534,217 | 6,259,115 | 6,000,214 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 742,649 | 617,983 | 481,219 | |||||||
Price | 1.80 7.78% | 1.67 -62.81% | 4.49 -73.07% | |||||||
Market cap | 1,336,769 29.53% | 1,032,031 -52.24% | 2,160,674 -51.91% | |||||||
EV | 1,521,490 | 1,185,872 | 2,414,162 | |||||||
EBITDA | 98,907 | 45,491 | 41,230 | |||||||
EV/EBITDA | 15.38 | 26.07 | 58.55 | |||||||
Interest | 49,264 | 13,587 | 39,680 | |||||||
Interest/NOPBT |